As of 2026-06-27, the Relative Valuation of Sangamo Therapeutics Inc (SGMO) is (6.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.18 USD, the upside of Sangamo Therapeutics Inc based on Relative Valuation is -3611.6%.
The range of the Relative Valuation is (5.72) - (6.73) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.2x - 24.8x | 21.0x |
| Forward P/E multiples | 19.2x - 22.6x | 20.9x |
| Fair Price | (5.72) - (6.73) | (6.24) |
| Upside | -3318.3% - -3888.2% | -3611.6% |
| Date | P/E |
| 2026-06-25 | -0.13 |
| 2026-06-24 | -0.15 |
| 2026-06-23 | -0.25 |
| 2026-06-22 | -0.59 |
| 2026-06-18 | -0.59 |
| 2026-06-17 | -0.60 |
| 2026-06-16 | -0.57 |
| 2026-06-15 | -0.55 |
| 2026-06-12 | -0.51 |
| 2026-06-11 | -0.49 |
| 2026-06-10 | -0.50 |
| 2026-06-09 | -0.50 |
| 2026-06-08 | -0.58 |
| 2026-06-05 | -0.72 |
| 2026-06-04 | -0.71 |
| 2026-06-03 | -0.73 |
| 2026-06-02 | -0.72 |
| 2026-06-01 | -0.71 |
| 2026-05-29 | -0.73 |
| 2026-05-28 | -0.70 |
| 2026-05-27 | -0.67 |
| 2026-05-26 | -0.62 |
| 2026-05-22 | -0.59 |
| 2026-05-21 | -0.52 |
| 2026-05-20 | -0.52 |
| 2026-05-19 | -0.49 |
| 2026-05-18 | -0.43 |
| 2026-05-15 | -0.45 |
| 2026-05-14 | -0.46 |
| 2026-05-13 | -0.48 |
| 2026-05-12 | -0.46 |
| 2026-05-11 | -0.41 |
| 2026-05-08 | -0.39 |
| 2026-05-07 | -0.34 |
| 2026-05-06 | -0.45 |
| 2026-05-05 | -0.37 |
| 2026-05-04 | -0.60 |
| 2026-05-01 | -0.45 |
| 2026-04-30 | -0.40 |
| 2026-04-29 | -0.45 |
| 2026-04-28 | -0.68 |
| 2026-04-27 | -0.71 |
| 2026-04-24 | -0.64 |
| 2026-04-23 | -0.86 |
| 2026-04-22 | -0.87 |
| 2026-04-21 | -0.86 |
| 2026-04-20 | -0.91 |
| 2026-04-17 | -0.88 |
| 2026-04-16 | -0.91 |
| 2026-04-15 | -0.92 |